Literature DB >> 3878749

Immunological abnormalities in thalassaemia major. I. A transfusion-related increase in circulating cytoplasmic immunoglobulin-positive cells.

A N Akbar, P J Giardina, M W Hilgartner, R W Grady.   

Abstract

Multiply transfused patients with beta-thalassaemia major have elevated serum immunoglobulin levels and a transfusion-related increase in (T8+) T-suppressor cells. We report here that these patients also have a significantly increased (P less than 0.001) proportion of B-cells that contain cytoplasmic immunoglobulin when visualized immediately upon isolation. On the other hand, the same cell populations do not exhibit an increase in the proportion of immunoglobulin-secreting cells as measured by a reverse haemolytic plaque assay. These results, together with those of ongoing studies, suggest that the cells containing the cytoplasmic immunoglobulin are likely to be terminally differentiated B-cells which persist in the circulation. While the reason for this phenomenon is not yet known, we have found that the increase in these cells is transfusion-related.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3878749      PMCID: PMC1577434     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Serum-immunoglobulin levels in thalassaemia and the effects of splenectomy.

Authors:  C Wasi; P Wasi; P Thongcharoen
Journal:  Lancet       Date:  1971-07-31       Impact factor: 79.321

2.  Lymphoid cell sets and serum immunoglobulins in patients with thalassaemia intermedia: relationship to serum iron and splenectomy.

Authors:  A Kapadia; M de Sousa; A L Markenson; D R Miller; R A Good; S Gupta
Journal:  Br J Haematol       Date:  1980-07       Impact factor: 6.998

3.  Serum immunoglobulin concentrations before and after splenectomy in patients with homozygous beta-thalassaemia.

Authors:  M Constantoulakis; D Trichopoulos; O Avgoustaki; J Economidou
Journal:  J Clin Pathol       Date:  1978-06       Impact factor: 3.411

4.  Chelation therapy in beta-thalassemia major. III. The role of splenectomy in achieving iron balance.

Authors:  J H Graziano; S Piomelli; M Hilgartner; P Giardina; M Karpatkin; M Andrew; N LoIacono; C Seaman
Journal:  J Pediatr       Date:  1981-11       Impact factor: 4.406

5.  Serum immunoglobulins in homozygous beta-thalassemia.

Authors:  P A Tovo; R Miniero; C Barbera; L Sacchetti; M Saitta
Journal:  Acta Haematol       Date:  1981       Impact factor: 2.195

6.  Circulating immunoglobulin-secreting cells in rheumatoid arthritis.

Authors:  I Pardo; A I Levinson
Journal:  Clin Immunol Immunopathol       Date:  1983-10

7.  B cell activity in systemic lupus erythematosus: depressed in vivo humoral immune response to a primary antigen (haemocyanin) and increased in vitro spontaneous immunoglobulin synthesis.

Authors:  C G Kallenberg; P C Limburg; C Van Slochteren; F J Van der Woude; T H The
Journal:  Clin Exp Immunol       Date:  1983-08       Impact factor: 4.330

8.  Disproportionate lymphoid cell subsets in thalassaemia major: the relative contributions of transfusion and splenectomy.

Authors:  R W Grady; A N Akbar; P J Giardina; M W Hilgartner; M de Sousa
Journal:  Br J Haematol       Date:  1985-04       Impact factor: 6.998

9.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

10.  Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2.

Authors:  L M Neckers; J Cossman
Journal:  Proc Natl Acad Sci U S A       Date:  1983-06       Impact factor: 11.205

View more
  7 in total

Review 1.  Immune cell functions in iron overload.

Authors:  M de Sousa
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

2.  Serum amyloid A protein concentration in bone marrow transplantation for beta thalassaemia.

Authors:  M Uguccioni; R Meliconi; E Lalli; S Nesci; C Delfini; G Lucarelli; G Gasbarrini; A Facchini
Journal:  J Clin Pathol       Date:  1992-04       Impact factor: 3.411

3.  The development of primed/memory CD8+ lymphocytes in vitro and in rejecting kidneys after transplantation.

Authors:  A N Akbar; P L Amlot; A Timms; G Lombardi; R Lechler; G Janossy
Journal:  Clin Exp Immunol       Date:  1990-08       Impact factor: 4.330

4.  Modulation of the defective natural killer activity seen in thalassaemia major with desferrioxamine and alpha-interferon.

Authors:  A N Akbar; P A Fitzgerald-Bocarsly; P J Giardina; M W Hilgartner; R W Grady
Journal:  Clin Exp Immunol       Date:  1987-11       Impact factor: 4.330

5.  Serum immunoglobulin levels in splenectomized and non- splenectomized patients with major Beta-thalassemia.

Authors:  Mojgan Kiani-Amin; Mohammadmehdi Daneshi; Parviz Ayazi; Shima Mohammadian; Nima Rezaei
Journal:  Iran J Pediatr       Date:  2011-03       Impact factor: 0.364

6.  Infections in thalassemia and hemoglobinopathies: focus on therapy-related complications.

Authors:  Bianca Maria Ricerca; Arturo Di Girolamo; Deborah Rund
Journal:  Mediterr J Hematol Infect Dis       Date:  2009-12-28       Impact factor: 2.576

7.  Immune responses in beta-thalassaemia: heme oxygenase 1 reduces cytokine production and bactericidal activity of human leucocytes.

Authors:  Arnone Nithichanon; Inthira Tussakhon; Waraporn Samer; Chidchamai Kewcharoenwong; Manabu Ato; Gregory J Bancroft; Ganjana Lertmemongkolchai
Journal:  Sci Rep       Date:  2020-06-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.